Majella Maher

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: University of Galway, Enterprise Ireland, Innogenetics N.v.. Active years: 2005-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Majella Maher. Retrieved from https://idiyas.com/inventor/majella-maher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 28.6

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 27(Granted Patents)

Location History:

Galway, IE (2005 - 2010)
County Galway, IE (2011)
Moycullen, IE (2016 - 2018)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2005-2018

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9944996 - eIF2γ gene as a diagnostic target for the identification of fungal and yeast species (2018-04-17),

2. 9745636 - SWI5 gene as a diagnostic target for the identification of fungal and yeast species (2017-08-29),

3. 9458514 - Nucleic acids probes for detection of yeast and fungal (2016-10-04),

4. 9243298 - [object Object] (2016-01-26),

5. 8029987 - Method for detecting C. albicans (2011-10-04),

6. 7741461 - Nucleic acid probes and methods for detecting clinically important fungal pathogens (2010-06-22),

7. 6858387 - Nucleic acid probes and methods for detecting clinically important fungal pathogens (2005-02-22),

Title: Majella Maher - Pioneering Patents in Fungal and Yeast Diagnostics

Introduction

Majella Maher, an accomplished inventor located in Moycullen, Ireland, has made significant contributions to the field of diagnostics through her innovative research. With a remarkable portfolio that includes seven patents, she has focused her work on identifying fungal and yeast species, which is crucial in various biological and medical contexts.

Latest Patents

Among her latest inventions is a diagnostic kit that utilizes the eIF2γ gene as a target for identifying yeast or fungal species. This innovative kit comprises at least one oligonucleotide probe that can bind to specific portions of the eIF2γ gene or its corresponding mRNA, enhancing the accuracy of diagnostics in this domain. Additionally, her work on the SWI5 gene further contributes to this field, with patented probes and primers that facilitate the detection and differentiation of fungal and yeast species in diagnostic assays.

Career Highlights

Throughout her career, Majella has worked with prestigious institutions such as the National University of Ireland, Galway, where she honed her research skills and contributed to groundbreaking studies. Her expertise in genetic diagnostics has positioned her as a leader in her field, enabling her to innovate and drive forward knowledge in fungal and yeast identification.

Collaborations

Majella's work has also involved collaboration with notable colleagues, including Terry James Smith and Thomas Gerard Barry. These partnerships have enhanced her research initiatives, allowing for a rich exchange of ideas and further advancements in the diagnostic processes she is passionate about.

Conclusion

Majella Maher's contributions to the field of diagnostics, particularly concerning fungal and yeast species, highlight her innovative spirit and dedication to scientific advancement. Her patents serve as valuable tools for researchers and medical professionals alike, underscoring the importance of her work in diagnostics and the broader implications for health and biology.

Profile summary based on public USPTO records.